School of Medicine, University College Dublin, Dublin, Ireland.
Division of Paediatric Infectious Diseases, Children's Health Ireland at Crumlin & Temple Street, Dublin, Ireland.
Hum Vaccin Immunother. 2021 Oct 3;17(10):3371-3376. doi: 10.1080/21645515.2021.1924018. Epub 2021 May 19.
Public health experts agree that pregnant women who fall into priority groups may be offered a Coronavirus Disease 2019 (COVID-19) vaccine. However, little is known about attitudes of pregnant women toward COVID-19 vaccination. We surveyed 300 pregnant women during the roll out of the Pfizer-BioNTech vaccine in Ireland. Women rated likelihood of receipt of a vaccine during pregnancy, on a 1-10 scale (1 = very unlikely, 10 = very likely). One hundred and thirteen (38%) women responded with a score of ≥8, while a similar proportion (36%) selected a score of ≤2. Safety of their unborn infant was the primary driver of decision making among survey participants, but specific safety concerns differed according to likely acceptance of a vaccine. Communication about COVID-19 vaccines to pregnant women must explicitly address safety. Pregnant women and their health-care providers should be supported with accessible interpretations of data so that they can make the best choice for their individual risk profile.
公共卫生专家一致认为，属于优先群体的孕妇可能会被提供 2019 冠状病毒病（COVID-19）疫苗。然而，对于孕妇对 COVID-19 疫苗接种的态度知之甚少。在爱尔兰辉瑞-生物科技疫苗推出期间，我们调查了 300 名孕妇。女性对怀孕期间接种疫苗的可能性进行了 1-10 分的评分（1=极不可能，10=极有可能）。113 名（38%）女性的评分≥8，而类似比例（36%）的女性选择评分≤2。在调查参与者中，未出生婴儿的安全性是决策的主要驱动因素，但根据对疫苗的可能接受程度，具体的安全问题有所不同。与孕妇沟通 COVID-19 疫苗时必须明确说明安全性。应向孕妇及其医疗保健提供者提供对数据的易懂解释，以便他们能够根据个人风险状况做出最佳选择。
